TY - JOUR
T1 - Comparison of multislice computed tomography findings between bicuspid and tricuspid aortic valves before and after transcatheter aortic valve implantation
AU - Watanabe, Yusuke
AU - Chevalier, Bernard
AU - Hayashida, Kentaro
AU - Leong, Tora
AU - Bouvier, Erik
AU - Arai, Takahide
AU - Farge, Arnaud
AU - Hovasse, Thomas
AU - Garot, Philippe
AU - Cormier, Bertrand
AU - Morice, Marie Claude
AU - Lefèvre, Thierry
PY - 2015/8/1
Y1 - 2015/8/1
N2 - Aims This study sought to compare the multislice computed tomography (MSCT) characteristics of bicuspid aortic valves (BAV) and tricuspid aortic valves (TAV) before and after implantation of the CoreValve (Medtronic, Santa Rosa, California) or the Edwards SapienXT (Edwards Lifesciences, Irvine, CA). Methods and Results From March 2009 to March 2013, a total of 67 TAVI patients who had both pre- and post-procedural MSCT were studied. Eleven patients underwent TAVI in BAV with the CoreValve (n-=-6) or SapienXT (n-=-5) and 56 patients underwent TAVI in TAV with the CoreValve (n-=-38) or SapienXT (n-=-18). The BAV group was similar to the TAV group except for a higher pre-procedural mean pressure gradient (53.1-±-17.4 vs. 48.8-±-20.4 mm Hg, P-=-0.03), a larger annulus perimeter (89.3-±-9.0 vs. 81.8-±-8.1 mm, P-=-0.03) and a higher aortic valve calcium volume (1262.7-±-396.0 vs. 556.4-±-461.9 mm3, P-<-0.01). In the CoreValve group, post-procedural mean pressure gradient was significantly higher in the BAV group (11.0-±-2.6 vs. 8.2-±-2.8 mm Hg, P-=-0.04) and a smaller valve area/pre-annulus area ratio was observed at each level of the prosthesis (base of the stent frame 81.7%-±-14.9% vs. 94.7%-±-15.0%, P-=-0.06, annulus level 74.3%-±-16.7% vs. 89.9%-±-10.5%, P-=-0.03, leaflet level 64.6%-±-13.1% vs. 81.2%-±-13.2%, P-<-0.01). This was not observed in the Edwards group. Conclusions Compared to TAV, patients with BAV have higher gradients, larger annulus perimeters and more calcified valves. Higher post procedural gradient and valve underexpansion were frequently observed after CoreValve implantation. Further MSCT study is required to demonstrate the efficacy of TAVI in BAV.
AB - Aims This study sought to compare the multislice computed tomography (MSCT) characteristics of bicuspid aortic valves (BAV) and tricuspid aortic valves (TAV) before and after implantation of the CoreValve (Medtronic, Santa Rosa, California) or the Edwards SapienXT (Edwards Lifesciences, Irvine, CA). Methods and Results From March 2009 to March 2013, a total of 67 TAVI patients who had both pre- and post-procedural MSCT were studied. Eleven patients underwent TAVI in BAV with the CoreValve (n-=-6) or SapienXT (n-=-5) and 56 patients underwent TAVI in TAV with the CoreValve (n-=-38) or SapienXT (n-=-18). The BAV group was similar to the TAV group except for a higher pre-procedural mean pressure gradient (53.1-±-17.4 vs. 48.8-±-20.4 mm Hg, P-=-0.03), a larger annulus perimeter (89.3-±-9.0 vs. 81.8-±-8.1 mm, P-=-0.03) and a higher aortic valve calcium volume (1262.7-±-396.0 vs. 556.4-±-461.9 mm3, P-<-0.01). In the CoreValve group, post-procedural mean pressure gradient was significantly higher in the BAV group (11.0-±-2.6 vs. 8.2-±-2.8 mm Hg, P-=-0.04) and a smaller valve area/pre-annulus area ratio was observed at each level of the prosthesis (base of the stent frame 81.7%-±-14.9% vs. 94.7%-±-15.0%, P-=-0.06, annulus level 74.3%-±-16.7% vs. 89.9%-±-10.5%, P-=-0.03, leaflet level 64.6%-±-13.1% vs. 81.2%-±-13.2%, P-<-0.01). This was not observed in the Edwards group. Conclusions Compared to TAV, patients with BAV have higher gradients, larger annulus perimeters and more calcified valves. Higher post procedural gradient and valve underexpansion were frequently observed after CoreValve implantation. Further MSCT study is required to demonstrate the efficacy of TAVI in BAV.
KW - bicuspid aortic valve
KW - multislice computed tomography
KW - transcatheter aortic valve implantation
UR - http://www.scopus.com/inward/record.url?scp=84937515196&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937515196&partnerID=8YFLogxK
U2 - 10.1002/ccd.25830
DO - 10.1002/ccd.25830
M3 - Article
C2 - 25594190
AN - SCOPUS:84937515196
SN - 1522-1946
VL - 86
SP - 323
EP - 330
JO - Catheterization and Cardiovascular Interventions
JF - Catheterization and Cardiovascular Interventions
IS - 2
ER -